Everence Capital Management Inc. Has $5.08 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Everence Capital Management Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,740 shares of the medical equipment provider’s stock after selling 190 shares during the period. Everence Capital Management Inc.’s holdings in Intuitive Surgical were worth $5,084,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of ISRG. Massachusetts Financial Services Co. MA acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $558,807,000. International Assets Investment Management LLC lifted its stake in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares during the last quarter. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC raised its holdings in Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after buying an additional 265,461 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 1.8 %

Intuitive Surgical stock traded up $9.21 on Friday, hitting $533.24. The company’s stock had a trading volume of 315,984 shares, compared to its average volume of 590,006. The firm has a market cap of $189.93 billion, a P/E ratio of 85.73, a price-to-earnings-growth ratio of 5.31 and a beta of 1.38. The company has a fifty day moving average price of $532.28 and a 200-day moving average price of $489.92. Intuitive Surgical, Inc. has a one year low of $320.26 and a one year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently commented on ISRG. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup upped their price target on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, Royal Bank of Canada lifted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.